MGNX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 11.30%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $1,436,379.53

MacroGenics Insider Trading History Chart

MacroGenics Share Price & Price History

^$3.18

+0.30 (1.20%)

As of 12/20/2024 06:31 PM ET

Days: 30 | 90 | 365

The #1 Coin for November 2024

From Crypto 101 Media | Ad

Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide…

You can get access to the report by clicking here now…

MacroGenics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/4/2024	Jeffrey Stuart Peters	VP	Sell	51,395	$15.55	$799,192.25
2/26/2024	Jeffrey Stuart Peters	VP	Sell	16,124	$17.22	$277,655.28	8,895
2/1/2024	Ezio Bonvini	SVP	Sell	13,316	$15.00	$199,740.00	74,668
1/19/2024	Ezio Bonvini	SVP	Sell	13,316	$12.00	$159,792.00	87,984
12/20/2023	Ezio Bonvini	SVP	Sell	18,880	$10.08	$190,310.40	101,300
10/2/2023	Target N V Biotech	Major Shareholder	Buy	150,000	$4.46	$669,000.00	9,929,963
9/7/2023	Target N V Biotech	Major Shareholder	Buy	200,000	$5.26	$1,052,000.00	9,779,963
8/30/2023	Edward Hurwitz	Director	Buy	15,000	$4.91	$73,650.00	33,074
3/10/2023	Jeffrey Stuart Peters	VP	Sell	5,372	$6.03	$32,393.16
2/14/2023	Target N V Biotech	Major Shareholder	Buy	500,000	$5.07	$2,535,000.00	9,579,963
1/19/2023	Target N V Biotech	Major Shareholder	Buy	150,000	$5.30	$795,000.00	9,079,963
12/27/2022	Target N V Biotech	Major Shareholder	Buy	200,000	$5.61	$1,122,000.00	8,929,963
12/23/2022	Target N V Biotech	Major Shareholder	Buy	200,000	$5.88	$1,176,000.00	8,729,963
11/22/2022	Target N V Biotech	Major Shareholder	Buy	300,000	$5.96	$1,788,000.00	8,529,963
10/24/2022	Target N V Biotech	Major Shareholder	Buy	250,000	$4.36	$1,090,000.00	8,229,963
10/21/2022	Target N V Biotech	Major Shareholder	Buy	250,000	$4.63	$1,157,500.00	7,979,963
10/19/2022	Target N V Biotech	Major Shareholder	Buy	168,422	$3.70	$623,161.40	7,443,986
6/15/2022	James Karrels	CFO	Buy	40,000	$2.47	$98,800.00	191,776

Nvidia’s Bold Move: Tackling Tech’s $1 Trillion Crisis

From Weiss Ratings | Ad

Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …

Find out details on these three critical Nvidia partners immediately.

SEC Filings (Institutional Ownership Changes) for MacroGenics (NASDAQ:MGNX)

96.89% of MacroGenics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

MacroGenics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/19/2024	Barclays PLC	98,753	$0.33M	0.0%	+97.1%	0.157%
11/16/2024	Geode Capital Management LLC	1,406,876	$4.63M	0.0%	-0.6%	2.242%
11/15/2024	Barclays PLC	98,753	$0.33M	0.0%	+97.1%	0.157%
11/15/2024	XTX Topco Ltd	11,178	$37K	0.0%	N/A	0.018%
11/15/2024	Wellington Management Group LLP	307,140	$1.01M	0.0%	+15.7%	0.489%
11/15/2024	State Street Corp	1,427,390	$4.70M	0.0%	-7.5%	2.274%
11/15/2024	Stifel Financial Corp	39,888	$0.13M	0.0%	+19.7%	0.064%
11/15/2024	Ikarian Capital LLC	80,079	$0.26M	0.0%	-60.0%	0.128%
11/15/2024	Jacobs Levy Equity Management Inc.	566,328	$1.86M	0.0%	+35.2%	0.902%
11/14/2024	Bellevue Group AG	9,929,963	$32.67M	0.5%	-0.1%	15.822%
11/14/2024	Wasatch Advisors LP	2,535,802	$8.34M	0.0%	+3.4%	4.040%
11/14/2024	PDT Partners LLC	160,039	$0.53M	0.0%	+44.5%	0.255%
11/14/2024	Verition Fund Management LLC	90,304	$0.30M	0.0%	N/A	0.144%
11/14/2024	Vestal Point Capital LP	830,000	$2.73M	0.2%	+3.8%	1.322%
11/14/2024	Walleye Capital LLC	114,744	$0.38M	0.0%	-43.7%	0.183%
11/14/2024	MetLife Investment Management LLC	15,093	$50K	0.0%	-57.5%	0.024%
11/13/2024	BNP Paribas Financial Markets	90,779	$0.30M	0.0%	+374.4%	0.145%
11/13/2024	FMR LLC	137,215	$0.45M	0.0%	+1,230.1%	0.219%
11/12/2024	Charles Schwab Investment Management Inc.	492,765	$1.62M	0.0%	-3.5%	0.785%
11/9/2024	Intech Investment Management LLC	20,763	$68K	0.0%	N/A	0.033%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	661,914	$2.18M	0.0%	+39.3%	1.055%
11/5/2024	GSA Capital Partners LLP	207,877	$0.68M	0.1%	+117.2%	0.331%
11/2/2024	XML Financial LLC	17,600	$58K	0.0%	+66.0%	0.028%
10/25/2024	Pinnacle Associates Ltd.	687,980	$2.26M	0.0%	+7.9%	1.097%
10/25/2024	China Universal Asset Management Co. Ltd.	12,064	$40K	0.0%	+64.0%	0.019%
10/10/2024	Exchange Traded Concepts LLC	48,823	$0.16M	0.0%	+260.8%	0.078%
10/3/2024	SG Americas Securities LLC	16,822	$55K	0.0%	N/A	0.027%
8/16/2024	Frazier Life Sciences Management L.P.	3,010,727	$12.80M	0.6%	+21.8%	4.807%
8/15/2024	Susquehanna Fundamental Investments LLC	129,996	$0.55M	0.0%	+22.9%	0.208%
8/15/2024	Millennium Management LLC	3,312,672	$14.08M	0.0%	+3,473.7%	5.289%
8/15/2024	AQR Capital Management LLC	143,161	$0.61M	0.0%	+74.5%	0.229%
8/15/2024	Armistice Capital LLC	6,000,000	$25.50M	0.3%	+150.0%	9.580%
8/14/2024	K2 Principal Fund L.P.	14,800	$63K	0.0%	N/A	0.024%
8/14/2024	Marshall Wace LLP	658,007	$2.80M	0.0%	+1,689.3%	1.051%
8/14/2024	DRW Securities LLC	13,105	$56K	0.0%	N/A	0.021%
8/14/2024	ProShare Advisors LLC	12,018	$51K	0.0%	-21.4%	0.019%
8/12/2024	Hsbc Holdings PLC	12,103	$50K	0.0%	-27.7%	0.019%
8/9/2024	Renaissance Technologies LLC	484,027	$2.06M	0.0%	-32.3%	0.773%
8/9/2024	Dimensional Fund Advisors LP	898,497	$3.82M	0.0%	-14.5%	1.435%
8/8/2024	Federated Hermes Inc.	300,499	$1.28M	0.0%	-33.8%	0.480%
8/6/2024	Acadian Asset Management LLC	586,079	$2.49M	0.0%	+23.8%	0.936%
8/3/2024	TD Asset Management Inc	169,000	$0.72M	0.0%	-20.8%	0.270%
8/1/2024	Rhumbline Advisers	88,294	$0.38M	0.0%	-5.2%	0.141%
7/30/2024	Pinnacle Associates Ltd.	637,319	$2.71M	0.0%	-1.5%	1.018%
7/29/2024	Principal Financial Group Inc.	348,421	$1.48M	0.0%	+1.1%	0.556%
7/29/2024	Panagora Asset Management Inc.	741,490	$3.15M	0.0%	+60.0%	1.184%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	16,072	$68K	0.0%	+300.6%	0.026%
7/26/2024	Bank of New York Mellon Corp	261,944	$1.11M	0.0%	+4.9%	0.418%
7/16/2024	Diversified Trust Co	18,097	$77K	0.0%	+32.8%	0.029%
5/17/2024	RA Capital Management L.P.	2,082,021	$30.65M	0.4%	-48.6%	3.324%
5/16/2024	California State Teachers Retirement System	47,955	$0.71M	0.0%	+378.7%	0.077%
5/16/2024	Jacobs Levy Equity Management Inc.	148,018	$2.18M	0.0%	+28.7%	0.236%
5/16/2024	Janus Henderson Group PLC	33,403	$0.49M	0.0%	N/A	0.053%
5/15/2024	Bellevue Group AG	9,965,862	$146.70M	2.2%	+0.1%	15.912%
5/15/2024	Price T Rowe Associates Inc. MD	2,438,050	$35.89M	0.0%	+8,361.6%	3.893%
5/15/2024	Avoro Capital Advisors LLC	6,150,000	$90.53M	1.1%	N/A	9.820%
5/14/2024	EntryPoint Capital LLC	2,695	$40K	0.0%	N/A	0.004%
5/14/2024	CANADA LIFE ASSURANCE Co	3,508	$52K	0.0%	N/A	0.006%
5/10/2024	Acadian Asset Management LLC	473,413	$6.97M	0.0%	-55.2%	0.757%
5/10/2024	Vanguard Group Inc.	3,677,678	$54.14M	0.0%	-14.7%	5.879%
5/8/2024	ProShare Advisors LLC	15,282	$0.23M	0.0%	+8.9%	0.024%
5/7/2024	Susquehanna Fundamental Investments LLC	105,787	$1.56M	0.1%	+597.4%	0.169%
5/7/2024	Susquehanna Portfolio Strategies LLC	58,624	$0.86M	0.0%	-60.7%	0.094%
5/7/2024	Swiss National Bank	91,800	$1.35M	0.0%	N/A	0.147%
5/7/2024	ClariVest Asset Management LLC	117,919	$1.74M	0.2%	-36.9%	0.188%
5/1/2024	BNP Paribas Financial Markets	35,313	$0.52M	0.0%	-16.1%	0.056%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	57,060	$0.84M	0.0%	+15.7%	0.091%
4/30/2024	Allspring Global Investments Holdings LLC	12,701	$0.19M	0.0%	-68.9%	0.020%
4/29/2024	Principal Financial Group Inc.	344,603	$5.07M	0.0%	+28.6%	0.551%
4/29/2024	China Universal Asset Management Co. Ltd.	11,935	$0.18M	0.0%	+66.4%	0.019%
4/26/2024	Pinnacle Associates Ltd.	647,235	$9.53M	0.2%	-5.9%	1.035%
4/18/2024	Wasatch Advisors LP	989,579	$14.57M	0.1%	-23.7%	1.582%
4/18/2024	Allspring Global Investments Holdings LLC	12,701	$0.19M	0.0%	-68.9%	0.020%
4/18/2024	Diversified Trust Co	13,630	$0.20M	0.0%	+16.0%	0.022%
4/15/2024	Sound Income Strategies LLC	5,252	$77K	0.0%	N/A	0.008%
4/5/2024	Los Angeles Capital Management LLC	53,113	$0.78M	0.0%	-12.0%	0.085%
3/5/2024	Wellington Management Group LLP	238,123	$2.29M	0.0%	-4.2%	0.384%
2/26/2024	Perceptive Advisors LLC	611,932	$5.89M	0.1%	N/A	0.987%
2/16/2024	Public Employees Retirement System of Ohio	9,144	$88K	0.0%	-24.7%	0.015%
2/15/2024	Frazier Life Sciences Management L.P.	2,401,704	$23.10M	1.2%	+33.2%	3.872%
2/14/2024	Pennant Investors LP	43,800	$0.42M	0.1%	N/A	0.071%
2/14/2024	Wasatch Advisors LP	1,297,574	$12.48M	0.1%	-7.9%	2.092%
2/14/2024	Bellevue Group AG	9,953,313	$95.75M	1.5%	+1.5%	16.046%
2/14/2024	XML Financial LLC	10,600	$0.10M	0.0%	-27.4%	0.017%
2/13/2024	Armistice Capital LLC	4,572,000	$43.98M	0.6%	-3.0%	7.371%
2/13/2024	Campbell & CO Investment Adviser LLC	93,005	$0.90M	0.1%	N/A	0.150%
2/9/2024	Trexquant Investment LP	58,679	$0.56M	0.0%	-64.8%	0.095%
2/9/2024	Dynamic Technology Lab Private Ltd	18,911	$0.18M	0.0%	N/A	0.030%
2/8/2024	Panagora Asset Management Inc.	398,944	$3.84M	0.0%	+5.4%	0.643%
2/8/2024	Massachusetts Financial Services Co. MA	165,107	$1.59M	0.0%	-15.0%	0.266%
2/7/2024	Principal Financial Group Inc.	267,876	$2.58M	0.0%	-2.8%	0.432%
2/7/2024	Jump Financial LLC	14,060	$0.14M	0.0%	N/A	0.023%
2/7/2024	BNP Paribas Financial Markets	42,109	$0.41M	0.0%	+144.5%	0.068%
2/6/2024	Charles Schwab Investment Management Inc.	833,500	$8.02M	0.0%	+1.0%	1.344%
2/6/2024	AJOVista LLC	5,344	$51K	0.1%	N/A	0.009%
2/6/2024	Amalgamated Bank	6,318	$61K	0.0%	-8.9%	0.010%
2/6/2024	Natixis Advisors L.P.	30,892	$0.30M	0.0%	N/A	0.050%
2/5/2024	Russell Investments Group Ltd.	15,342	$0.15M	0.0%	-47.1%	0.025%
1/31/2024	Federated Hermes Inc.	803,375	$7.73M	0.0%	-13.6%	1.295%
1/30/2024	Cornercap Investment Counsel Inc.	29,110	$0.28M	0.0%	-17.6%	0.047%

Data available starting January 2016

MacroGenics, Inc., a biopharmaceutical company, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. The company's pipeline of immuno-oncology product candidates includes MGC018, an antibody drug conjugate (ADC), which targets solid tumors expressing B7-H3; Enoblituzumab, a monoclonal antibody that targets B7-H3; and MGD024, an investigational bispecific CD123 × CD3 DART molecule to minimize cytokine-release syndrome for patients with hematologic malignancies. In addition, it develops Lorigerlimab, a monoclonal antibody that targets the immune checkpoints PD-1 and cytotoxic T-lymphocyte-associated protein 4; Tebotelimab, an investigational tetravalent DART molecule for PD-1 and lymphocyte-activation gene 3; Retifanlimab, a humanized monoclonal antibody targeting programmed death receptor-1; and IMGC936, an ADC that targets ADAM9, a cell surface protein over-expressed in various solid tumor types. Further, the company develops MGD014 and MGD020, a DART molecule to target the envelope protein of human immunodeficiency virus infected cells and CD3 on T cells; Teplizumab for the treatment of type 1 diabetes; and PRV-3279, a CD32B × CD79B DART molecule for the treatment of autoimmune indications. It has collaborations with Incyte Corporation; Zai Lab Limited; I-Mab Biopharma; and Janssen Biotech, Inc. The company was incorporated in 2000 and is headquartered in Rockville, Maryland.

Today's Range

Now: $3.18

$3.13

$3.26

50 Day Range

MA: $3.64

$3.18

$4.46

52 Week Range

Now: $3.18

$2.95

$21.88

Volume

722,084 shs

Average Volume

469,202 shs

Market Capitalization

$199.58 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.04

Who are the company insiders with the largest holdings of MacroGenics?: MacroGenics' top insider shareholders include:
Target N V Biotech (Major Shareholder)
Ezio Bonvini (SVP)
Edward Hurwitz (Director)
Jeffrey Stuart Peters (VP)
Learn More about top insider investors at MacroGenics.
Who are the major institutional investors of MacroGenics?: MacroGenics' top institutional investors include:
Bellevue Group AG — 15.82%
Wasatch Advisors LP — 4.04%
State Street Corp — 2.27%
Geode Capital Management LLC — 2.24%
Vestal Point Capital LP — 1.32%
Pinnacle Associates Ltd. — 1.10%
Learn More about top institutional investors of MacroGenics stock.
Which major investors are selling MacroGenics stock?: During the last quarter, MGNX stock was sold by these institutional investors:
Ikarian Capital LLC
State Street Corp
Walleye Capital LLC
Parallax Volatility Advisers L.P.
MetLife Investment Management LLC
Charles Schwab Investment Management Inc.
Bellevue Group AG
Geode Capital Management LLC
In the previous year, company insiders that have sold MacroGenics company stock include:
Target N V Biotech (Major Shareholder)
Ezio Bonvini (SVP)
Learn More investors selling MacroGenics stock.
Which major investors are buying MacroGenics stock?: During the previous quarter, MGNX stock was purchased by institutional investors including:
Connor Clark & Lunn Investment Management Ltd.
Jacobs Levy Equity Management Inc.
FMR LLC
GSA Capital Partners LLP
Verition Fund Management LLC
Wasatch Advisors LP
BNP Paribas Financial Markets
Pinnacle Associates Ltd.
Within the previous year, these company insiders have bought MacroGenics stock:
Target N V Biotech (Major Shareholder)
Ezio Bonvini (SVP)
Learn More investors buying MacroGenics stock.

From Behind the Markets | Ad

My research indicates there is only one investment that can meet AI's unprecedented demand for energy.

Click to get the name and ticker symbol